Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B Tian
Discovery of a BTK/MNK Dual Inhibitor for Lymphoma and Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
Dual Targeting of eIF4E by Blocking MNK and mTOR Pathways in Leukemia
Cytokine
Biochemistry
Allergy
Immunology
Hematology
Molecular Biology
Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor
International Journal of Basic & Clinical Pharmacology
The BTK Inhibitor Zanubrutinib (BGB-3111) Demonstrated Synergies With Other Anti-Lymphoma Targeted Agents
Haematologica
Hematology
Discovery of a Potent BTK Inhibitor With a Novel Binding Mode by Using Parallel Selections With a DNA-Encoded Chemical Library
ChemBioChem
Organic Chemistry
Biochemistry
Molecular Medicine
Molecular Biology
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
Acalabrutinib (ACP-196): A Selective Second-Generation BTK Inhibitor
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia
Scientific Reports
Multidisciplinary
Discovery of a Potent Dual Inhibitor of Wild-Type and Mutant Respiratory Syncytial Virus Fusion Proteins